Indoco Remedies is currently trading at Rs. 190.90, up by 8.90 points or 4.89% from its previous closing of Rs. 182.00 on the BSE.
The scrip opened at Rs. 188.45 and has touched a high and low of Rs. 210.40 and Rs. 177.55 respectively. So far 11409 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 296.65 on 29-Jan-2018 and a 52 week low of Rs. 150.25 on 08-Oct-2018.
Last one week high and low of the scrip stood at Rs. 223.95 and Rs. 177.55 respectively. The current market cap of the company is Rs. 1713.08 crore.
The promoters holding in the company stood at 58.83%, while Institutions and Non-Institutions held 16.21% and 24.96% respectively.
US Food and Drug Administration (USFDA) has concluded inspection at Indoco Remedies’ Goa Plant I (Oral Dosages Facility) with issuing 6 observations (483s) to the site. None of these observations are critical in nature. The company will respond to these observations within the stipulated time of 15 days.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
